RS51232B - Novi postupak sinteze derivata 1,3,4,5-tetrahidro-2h-3benzazepin-2-on-a i primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom - Google Patents

Novi postupak sinteze derivata 1,3,4,5-tetrahidro-2h-3benzazepin-2-on-a i primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom

Info

Publication number
RS51232B
RS51232B RSP-2010/0006A RSP20100006A RS51232B RS 51232 B RS51232 B RS 51232B RS P20100006 A RSP20100006 A RS P20100006A RS 51232 B RS51232 B RS 51232B
Authority
RS
Serbia
Prior art keywords
synthesis
ivabradine
benzazepin
tetrahydro
derivatives
Prior art date
Application number
RSP-2010/0006A
Other languages
English (en)
Inventor
Jean-Michel Lerestif
Jean-Pierre Lecouve
Daniel Brigot
Jean-Claude Souvie
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of RS51232B publication Critical patent/RS51232B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Postupak za sintezu jedinjenja formule (I):u kojoj R1 i R2, isti ili različiti, svaki predstavlja linearnu ili razgranatu alkoksi(C1-C8)grupu ili obrazuju, zajedno sa ugljenikovim atomom koji ih nosi, 1,3-dioksanski, 1,3-dioksolanski ili 1,3-dioksepanski prsten, naznačen time što se jedinjenje formule (VI):u kojoj su R1 i R2, kao što su prethodno definisani, podvrgava reakciji katalitičke hidrogenacije, u ne-kiselom rastvaraču, zatim se reakciona mešavina filtrira da bi se dobilo jedinjenje formule (I).Prijava sadrži još 8 patentnih zahteva.
RSP-2010/0006A 2004-04-13 2005-02-21 Novi postupak sinteze derivata 1,3,4,5-tetrahidro-2h-3benzazepin-2-on-a i primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom RS51232B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403828A FR2868775B1 (fr) 2004-04-13 2004-04-13 Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
RS51232B true RS51232B (sr) 2010-12-31

Family

ID=34941961

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2010/0006A RS51232B (sr) 2004-04-13 2005-02-21 Novi postupak sinteze derivata 1,3,4,5-tetrahidro-2h-3benzazepin-2-on-a i primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom

Country Status (33)

Country Link
US (1) US7064200B2 (sr)
EP (1) EP1614687B1 (sr)
JP (2) JP4515933B2 (sr)
KR (1) KR100636499B1 (sr)
CN (1) CN100348585C (sr)
AR (1) AR047707A1 (sr)
AT (1) ATE448221T1 (sr)
AU (1) AU2005200884B2 (sr)
BR (1) BRPI0500590B8 (sr)
CA (1) CA2496712C (sr)
CY (1) CY1109740T1 (sr)
DE (1) DE602005017541D1 (sr)
DK (1) DK1614687T3 (sr)
EA (1) EA007743B1 (sr)
EG (1) EG25619A (sr)
ES (1) ES2336461T3 (sr)
FR (1) FR2868775B1 (sr)
GE (1) GEP20074136B (sr)
HK (1) HK1079777A1 (sr)
HR (1) HRP20100024T1 (sr)
MA (1) MA27598A1 (sr)
MX (1) MXPA05003696A (sr)
MY (1) MY140904A (sr)
NO (1) NO329861B1 (sr)
NZ (1) NZ538328A (sr)
PL (1) PL1614687T3 (sr)
PT (1) PT1614687E (sr)
RS (1) RS51232B (sr)
SG (1) SG116574A1 (sr)
SI (1) SI1614687T1 (sr)
UA (1) UA81773C2 (sr)
WO (1) WO2005111027A1 (sr)
ZA (1) ZA200501468B (sr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
EP2471780B1 (en) 2007-05-30 2014-11-26 Ind-Swift Laboratories Limited Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
ES2402765T3 (es) 2008-12-22 2013-05-08 Krka, D.D., Novo Mesto Procedimiento de preparación de ivabradina
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
EA201290772A1 (ru) 2010-02-12 2013-02-28 КРКА, д.д., НОВО МЕСТО Новые формы ивабрадина гидрохлорида
FR2956401B1 (fr) * 2010-02-17 2012-02-03 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2993561B1 (fr) * 2012-07-17 2014-10-31 Servier Lab Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3519735A1 (de) * 1985-06-01 1986-12-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
AU2005200884A1 (en) 2005-10-27
SI1614687T1 (sl) 2010-01-29
SG116574A1 (en) 2005-11-28
JP2005298478A (ja) 2005-10-27
JP5277130B2 (ja) 2013-08-28
MA27598A1 (fr) 2005-11-01
CN1683343A (zh) 2005-10-19
AU2005200884B2 (en) 2010-07-15
ZA200501468B (en) 2005-11-30
UA81773C2 (uk) 2008-02-11
EP1614687A1 (fr) 2006-01-11
NO329861B1 (no) 2011-01-17
CY1109740T1 (el) 2014-09-10
MXPA05003696A (es) 2006-01-24
ES2336461T3 (es) 2010-04-13
PT1614687E (pt) 2009-12-02
KR20060042117A (ko) 2006-05-12
NO20050888D0 (no) 2005-02-18
GEP20074136B (en) 2007-06-25
WO2005111027A1 (fr) 2005-11-24
CN100348585C (zh) 2007-11-14
CA2496712A1 (fr) 2005-10-13
EP1614687B1 (fr) 2009-11-11
FR2868775B1 (fr) 2008-04-11
MY140904A (en) 2010-01-29
JP4515933B2 (ja) 2010-08-04
HRP20100024T1 (hr) 2010-02-28
PL1614687T3 (pl) 2010-04-30
ATE448221T1 (de) 2009-11-15
NZ538328A (en) 2005-10-28
FR2868775A1 (fr) 2005-10-14
DK1614687T3 (da) 2010-03-29
US20050228178A1 (en) 2005-10-13
JP2010047577A (ja) 2010-03-04
DE602005017541D1 (de) 2009-12-24
EA200500240A1 (ru) 2005-10-27
KR100636499B1 (ko) 2006-10-18
AR047707A1 (es) 2006-02-08
HK1079777A1 (en) 2006-04-13
CA2496712C (fr) 2010-04-06
US7064200B2 (en) 2006-06-20
NO20050888L (no) 2005-10-14
BRPI0500590A (pt) 2005-11-16
EA007743B1 (ru) 2006-12-29
EG25619A (en) 2012-03-26
BRPI0500590B1 (pt) 2018-10-09
BRPI0500590B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
RS51232B (sr) Novi postupak sinteze derivata 1,3,4,5-tetrahidro-2h-3benzazepin-2-on-a i primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
Mattson et al. An improved method for reductive alkylation of amines using titanium (IV) isopropoxide and sodium cyanoborohydride
RS50511B (sr) Postupak za sintezu ivabradina i njegovih farmaceutski prihvatljivih aditivnih soli kiselina
RS52542B (sr) Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
Nelson et al. Absolute configuration of glycerol derivatives. 5. Oxprenolol enantiomers
ATE361924T1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
TN2009000160A1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoides
Pu et al. Doubly stereocontrolled asymmetric conjugate addition of acetylacetone to nitroolefins catalyzed by bifunctional tertiary amine–thiourea catalysts derived from both acyclic α-amino acids and carbohydrates
JP2008517983A5 (sr)
RS53495B1 (sr) Postupak za sintezu 7,8-dimetoksi-1,3-dihidro-2h-3-benzazepin-2-ona i, njegova primena u sintezi ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
RU2001106631A (ru) Производные бензола и их фармацевтическое применение
ATE381559T1 (de) Adamantan- und azabicyclooctan- und - nonanderivate, verfahren zu deren herstellung und deren verwendung als dpp-iv-inhibitoren
ATE501103T1 (de) Organische verbindungen
RS50546B (sr) Postupak sinteze derivata 1,3-dihidro-2h-3-benzazepin-2-on-a i primena u sintezi ivabradina i adicionih soli farmaceutski prihvatljive kiseliine
TNSN07357A1 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
CN101180263B (zh) 取代四氟苄基苯胺化合物及其药学可接受的盐的制备方法
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
HRP20080315T3 (en) Process for synthesizing (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine
EA200702587A1 (ru) Способ синтеза промежуточных продуктов, предназначенных для получения трициклических бензимидазолов
WO2008134578A3 (en) Synthesis of optically active radio-labeled reverse transcriptase inhibitors
RS52699B (sr) Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
NO330989B1 (no) Nye piperazinderivater, fremgangsmater for fremstilling av slike og deres anvendelse som syntesemellomprodukter.
Nakatani et al. Enantioselective total synthesis of (2R, 3R, 6R)-N-methyl-6-(deca-1′, 3′, 5′-trienyl)-3-methoxy-2-methylpiperidine, an insecticidal alkaloid
MX2007009506A (es) Quimicos de aroma con base de schiff y producto de adicion michael.
ATE493522T1 (de) Elektrochemische herstellung sterisch gehinderter amine